US$ 28.13
ghk cu tolerance desensitization downregulation Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy Frontiers | Exploring the beneficial
Description
If you are tired and stressed (burning the candle at both ends

We don't think that's quite worth $60/month (or even $50 if you subscribe)

Theyre definitely a good idea to place in a research design or methodology section

doi: 10.1016/j.ijbiomac.2021.04.119
